학술 논문 - 예방 및 백신

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020)
작성자
대한감염학회
링크
작성일
2020-11-30
조회
525